GLP1R and heart failure: Similarly, Kristensen et al. found that GLP1-RA have cardiorenal protection with reduction of major adverse cardiac events outcomes by 12%, hospital admission of heart failure by 9%, and broad composite kidney outcomes by 17% [3].